The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Jain & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cian Healthcare Ltd has informed the exchange about a preferential allotment of 2,37,50,000 equity shares (95% of expanded capital) to promoter Mr. Rajesh Jain and persons acting in concert (Ananta Medicare Ltd and Pradeep Kumar Jain) under a Resolution Plan approved by NCLT Mumbai on December 18, 2025. Rajesh Jain received 52.5 lakh shares (21%) and the PACs received 1.85 crore shares (74%), taking the total promoter group holding to 95% post-allotment. The company's equity share capital expanded sharply from ₹1.25 crore (12.5 lakh shares) to ₹25 crore (2.5 crore shares), a 20-fold increase. The acquisition was completed on March 16, 2026.
This is a significant control event — the promoter group now effectively owns 95% of Cian Healthcare, leaving very little free float for public shareholders. The 20x expansion of share capital through a preferential route will dilute non-promoter shareholders substantially and may weigh on share price and liquidity. Minority investors should note the extremely low public holding going forward.